Neuropharmacology & Neurotherapeutics
SSRIs
Oct. 21, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Coronal MRI with hypointensity on T1 (A) and increased FLAIR in the right peri-insular region (B) (white arrows). One month later, the area of inflammation is much larger (C and D; white arrow). FDG-PET scan showed patchy areas of increased metabolism in the right frontal lobe (E) surrounded by hypometabolism on the FDG-PET/MRI coregistration in the peri-insular region (F). Cut surface of the resected insular region shows diffuse cortical atrophy and necrosis (G; arrow). Histopathology was consistent with Rasmussen syndrome by demonstrating astrogliosis, neuronal loss, and lymphocytic aggregates (H). (Contributed by Dr. Gary Mathern.)